IS4641A - 4-Arýl-1-fenýlalkýl-1.2.3.6-tetrahýdrópýridín semhafa tauganærandi og taugaverjandi virkni - Google Patents

4-Arýl-1-fenýlalkýl-1.2.3.6-tetrahýdrópýridín semhafa tauganærandi og taugaverjandi virkni

Info

Publication number: IS4641A
Authority: IS; Iceland
Prior art keywords: alkyl; tetrahydropyridine; aryl; phenylalkyl; neuromuscular
Prior art date: 1995-06-28

Application number

IS4641A

Other languages

English (en)

Other versions

IS1999B (is

Inventor

Badone Domenico

Baroni Marco

Cardamone Rosanna

Fournier Jacqueline

Guzzi Umberto

Ielmini Alessandra

Original Assignee

Sanofi-Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-28

Filing date

1997-12-23

Publication date

1997-12-23

1997-12-23 Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis

1997-12-23 Publication of IS4641A publication Critical patent/IS4641A/is

2005-04-15 Publication of IS1999B publication Critical patent/IS1999B/is

Links

230000000694 effects Effects 0.000 title 1
230000002232 neuromuscular Effects 0.000 title 1
239000002858 neurotransmitter agent Substances 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 4
125000003545 alkoxy group Chemical group 0.000 abstract 3
-1 phenoxy, phenylamino Chemical group 0.000 abstract 3
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
PUAQLLVFLMYYJJ-UHFFFAOYSA-N 2-aminopropiophenone Chemical compound CC(N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-UHFFFAOYSA-N 0.000 abstract 1
150000003863 ammonium salts Chemical class 0.000 abstract 1
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
125000005111 carboxyalkoxy group Chemical group 0.000 abstract 1
125000004181 carboxyalkyl group Chemical group 0.000 abstract 1
125000000000 cycloalkoxy group Chemical group 0.000 abstract 1
125000006310 cycloalkyl amino group Chemical group 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
125000004981 cycloalkylmethyl group Chemical group 0.000 abstract 1
125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 abstract 1
125000001475 halogen functional group Chemical group 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
125000005504 styryl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Neurology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

IS4641A 1995-06-28 1997-12-23 4-Arýl-1-fenýlalkýl-1.2.3.6-tetrahýdrópýridín semhafa tauganærandi og taugaverjandi virkni IS1999B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9507760A FR2736053B1 (fr)	1995-06-28	1995-06-28	Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines
PCT/FR1996/000995 WO1997001536A1 (fr)	1995-06-28	1996-06-26	4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines ayant une activite neurotrophique et neuroprotectrice

Publications (2)

Publication Number	Publication Date
IS4641A true IS4641A (is)	1997-12-23
IS1999B IS1999B (is)	2005-04-15

Family

ID=9480466

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS4641A IS1999B (is)	1995-06-28	1997-12-23	4-Arýl-1-fenýlalkýl-1.2.3.6-tetrahýdrópýridín semhafa tauganærandi og taugaverjandi virkni

Country Status (29)

Country	Link
US (1)	US5981754A (is)
EP (2)	EP1216996A3 (is)
JP (2)	JP3147906B2 (is)
KR (1)	KR100460581B1 (is)
CN (1)	CN1153765C (is)
AT (1)	ATE223897T1 (is)
AU (1)	AU715090B2 (is)
BR (1)	BR9608662A (is)
CA (1)	CA2225746C (is)
CY (1)	CY2312B1 (is)
CZ (1)	CZ291075B6 (is)
DE (1)	DE69623631T2 (is)
DK (1)	DK0837848T3 (is)
EE (1)	EE03870B1 (is)
ES (1)	ES2183965T3 (is)
FR (1)	FR2736053B1 (is)
HU (1)	HUP9900055A3 (is)
IL (1)	IL122159A (is)
IS (1)	IS1999B (is)
NO (1)	NO310144B1 (is)
NZ (1)	NZ312723A (is)
PL (2)	PL187087B1 (is)
PT (1)	PT837848E (is)
RU (1)	RU2163237C2 (is)
SK (2)	SK283707B6 (is)
TR (1)	TR199701710T1 (is)
UA (1)	UA62914C2 (is)
WO (1)	WO1997001536A1 (is)
ZA (1)	ZA965527B (is)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2762514B1 (fr)	1997-04-29	1999-10-22	Sanofi Sa	Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation
FR2763847B1 (fr) *	1997-05-28	2003-06-06	Sanofi Sa	Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
FR2771007B1 (fr) *	1997-11-14	2000-12-01	Sanofi Sa	Association de principes actifs pour le traitement de la demence senile du type alzheimer
CO4980891A1 (es) *	1997-11-14	2000-11-27	Sanofi Sa	Asociacion de principios activos para el tratamiento de la demencia senil de tipo azheimer
FR2771006B1 (fr) *	1997-11-14	2000-12-01	Sanofi Sa	Association de principes actifs pour le traitement de la demence senile du type alzheimer
JP2002518386A (ja) *	1998-06-19	2002-06-25	イーライ・リリー・アンド・カンパニー	ヘテロアリール化合物の製造
FR2803593B1 (fr) *	2000-01-06	2002-02-15	Sanofi Synthelabo	Nouvelles tetrahydropyridines, procede pour leur preparation et compositions pharmaceutiques les contenant
JP4324382B2 (ja)	2001-04-20	2009-09-02	サノフィ−アベンティス	テトラヒドロピリジル−アルキル−複素環、その製造方法およびそれを含む医薬組成物
FR2823748B1 (fr) *	2001-04-20	2004-02-20	Sanofi Synthelabo	Tetrahydropyridyl-alkyl-benzodiazines, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2840896B1 (fr) *	2002-06-18	2005-04-08	Sanofi Synthelabo	Phenyl-et pyridyl-piperazines, procede pour leur preparation et compositions pharmaceutiques les contenant
CN1726209B (zh) *	2002-12-16	2011-04-13	三菱制药株式会社	3-取代的-4-嘧啶酮衍生物
WO2005016910A1 (ja)	2003-08-18	2005-02-24	Sankio Chemical Co., Ltd.	ピリジルテトラヒドロピリジン類およびピリジルピペリジン類とそれらの製造方法
TWI350168B (en)	2004-05-07	2011-10-11	Incyte Corp	Amido compounds and their use as pharmaceuticals
CA2584502A1 (en) *	2004-06-24	2006-01-05	Incyte Corporation	2-methylpropanamides and their use as pharmaceuticals
EP1758882A4 (en) *	2004-06-24	2008-01-23	Incyte Corp	AMID COMPOUNDS AND THEIR USE AS MEDICAMENTS
US8071624B2 (en) *	2004-06-24	2011-12-06	Incyte Corporation	N-substituted piperidines and their use as pharmaceuticals
EA200700118A1 (ru) *	2004-06-24	2007-08-31	Инсайт Корпорейшн	Амидосоединения и их применение в качестве лекарственных средств
JP2008504279A (ja) *	2004-06-24	2008-02-14	インサイト・コーポレイション	アミド化合物およびその医薬としての使用
EA200700251A1 (ru) *	2004-08-10	2007-08-31	Инсайт Корпорейшн	Амидосоединения и их применение в качестве фармацевтических средств
US8110581B2 (en)	2004-11-10	2012-02-07	Incyte Corporation	Lactam compounds and their use as pharmaceuticals
EP1812005B1 (en) *	2004-11-10	2015-09-16	Incyte Corporation	Lactam compounds and their use as pharmaceuticals
JP2008520700A (ja) *	2004-11-18	2008-06-19	インサイト・コーポレイション	１１−βヒドロキシルステロイドデヒドロゲナーゼタイプＩの阻害剤およびその使用方法
FR2883285B1 (fr) *	2005-03-17	2007-05-18	Sanofi Aventis Sa	Sel besylate de la 7-(2-(4-(3-trifluoromethyl-phenyl) -1,2,3,6-tetrahudro-pyrid-1-yl)ethyl) isoquinoleine, sa preparation et son utilisation en therapeutique
JP4864342B2 (ja) *	2005-04-27	2012-02-01	北興化学工業株式会社	ビアリール化合物の製造方法
WO2007038138A2 (en) *	2005-09-21	2007-04-05	Incyte Corporation	Amido compounds and their use as pharmaceuticals
AU2006322060A1 (en) *	2005-12-05	2007-06-14	Incyte Corporation	Lactam compounds and methods of using the same
WO2007084314A2 (en) *	2006-01-12	2007-07-26	Incyte Corporation	MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
EA200870216A1 (ru) *	2006-01-31	2009-02-27	Инсайт Корпорейшн	Амидо соединения и их применение в качестве лекарственных средств
US20070213311A1 (en) *	2006-03-02	2007-09-13	Yun-Long Li	Modulators of 11-beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
WO2007103719A2 (en) *	2006-03-03	2007-09-13	Incyte Corporation	MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
US20070293529A1 (en) *	2006-05-01	2007-12-20	Yun-Long Li	Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
JP2009537564A (ja) *	2006-05-17	2009-10-29	インサイト・コーポレイション	１１−βヒドロキシルステロイドデヒドロゲナーゼタイプＩの複素環阻害剤およびそれを用いる方法
CL2008001839A1 (es)	2007-06-21	2009-01-16	Incyte Holdings Corp	Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
KR20100135711A (ko)	2007-12-20	2010-12-27	엔비보 파마슈티칼즈, 인코퍼레이티드	사중치환된 벤젠
DK2526081T3 (en) *	2010-01-19	2015-10-05	Bayer Ip Gmbh	METHOD OF PRODUCING aryl and HETEROARYLEDDIKESYREDERIVATER
WO2018195649A1 (en) *	2017-04-26	2018-11-01	Alberta Research Chemicals Inc.	Substituted tetrahydropyridine derivatives as ido-1 inhibitors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2098248T3 (es) *	1989-05-17	1997-05-01	Pfizer	Derivados de 2-piperidino-1-alcanoles como agentes antiisquemicos.
FR2650505B1 (fr) *	1989-08-07	1994-06-03	Midy Spa	Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
FR2662355B1 (fr) *	1990-05-22	1994-11-10	Sanofi Sa	Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
HU211019B (en) *	1991-12-02	1995-09-28	Richter Gedeon Vegyeszet	Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
DE4325855A1 (de) *	1993-08-02	1995-02-09	Boehringer Ingelheim Kg	Neue Benzoesäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

1995
- 1995-06-28 FR FR9507760A patent/FR2736053B1/fr not_active Expired - Fee Related
1996
- 1996-06-26 JP JP50420697A patent/JP3147906B2/ja not_active Expired - Fee Related
- 1996-06-26 DE DE69623631T patent/DE69623631T2/de not_active Expired - Fee Related
- 1996-06-26 EE EE9700348A patent/EE03870B1/xx not_active IP Right Cessation
- 1996-06-26 CN CNB961950900A patent/CN1153765C/zh not_active Expired - Fee Related
- 1996-06-26 EP EP02006482A patent/EP1216996A3/fr not_active Withdrawn
- 1996-06-26 US US08/973,712 patent/US5981754A/en not_active Expired - Fee Related
- 1996-06-26 DK DK96924023T patent/DK0837848T3/da active
- 1996-06-26 KR KR1019970709747A patent/KR100460581B1/ko not_active Expired - Fee Related
- 1996-06-26 SK SK1781-97A patent/SK283707B6/sk unknown
- 1996-06-26 PT PT96924023T patent/PT837848E/pt unknown
- 1996-06-26 PL PL96324216A patent/PL187087B1/pl not_active IP Right Cessation
- 1996-06-26 EP EP96924023A patent/EP0837848B1/fr not_active Expired - Lifetime
- 1996-06-26 TR TR97/01710T patent/TR199701710T1/xx unknown
- 1996-06-26 RU RU98101492/04A patent/RU2163237C2/ru not_active IP Right Cessation
- 1996-06-26 NZ NZ312723A patent/NZ312723A/en unknown
- 1996-06-26 CZ CZ19974222A patent/CZ291075B6/cs not_active IP Right Cessation
- 1996-06-26 IL IL12215996A patent/IL122159A/en not_active IP Right Cessation
- 1996-06-26 BR BR9608662A patent/BR9608662A/pt not_active IP Right Cessation
- 1996-06-26 CA CA002225746A patent/CA2225746C/en not_active Expired - Fee Related
- 1996-06-26 UA UA97126360A patent/UA62914C2/uk unknown
- 1996-06-26 PL PL357052A patent/PL192353B1/pl not_active IP Right Cessation
- 1996-06-26 ES ES96924023T patent/ES2183965T3/es not_active Expired - Lifetime
- 1996-06-26 AU AU64619/96A patent/AU715090B2/en not_active Ceased
- 1996-06-26 WO PCT/FR1996/000995 patent/WO1997001536A1/fr not_active Ceased
- 1996-06-26 SK SK593-2003A patent/SK285433B6/sk unknown
- 1996-06-26 AT AT96924023T patent/ATE223897T1/de not_active IP Right Cessation
- 1996-06-26 HU HU9900055A patent/HUP9900055A3/hu unknown
- 1996-06-28 ZA ZA965527A patent/ZA965527B/xx unknown
1997
- 1997-12-23 NO NO19976079A patent/NO310144B1/no unknown
- 1997-12-23 IS IS4641A patent/IS1999B/is unknown
2000
- 2000-07-31 JP JP2000231069A patent/JP3302351B2/ja not_active Expired - Fee Related
2003
- 2003-01-15 CY CY0300004A patent/CY2312B1/xx unknown

Also Published As

Publication number	Publication date
EE03870B1 (et)	2002-10-15
PL324216A1 (en)	1998-05-11
FR2736053A1 (fr)	1997-01-03
JP3147906B2 (ja)	2001-03-19
ES2183965T3 (es)	2003-04-01
CZ422297A3 (cs)	1998-04-15
RU2163237C2 (ru)	2001-02-20
DE69623631T2 (de)	2003-08-07
JP2001114763A (ja)	2001-04-24
ZA965527B (en)	1997-01-24
KR19990028431A (ko)	1999-04-15
NZ312723A (en)	1999-10-28
IL122159A (en)	2001-06-14
WO1997001536A1 (fr)	1997-01-16
JP3302351B2 (ja)	2002-07-15
EP0837848B1 (fr)	2002-09-11
CA2225746A1 (en)	1997-01-16
BR9608662A (pt)	1999-05-04
IL122159A0 (en)	1998-04-05
DE69623631D1 (en)	2002-10-17
NO976079L (no)	1997-12-23
SK285433B6 (sk)	2007-01-04
JPH11506118A (ja)	1999-06-02
CZ291075B6 (cs)	2002-12-11
CN1153765C (zh)	2004-06-16
EP1216996A3 (fr)	2003-10-15
CY2312B1 (en)	2003-11-14
EE9700348A (et)	1998-06-15
IS1999B (is)	2005-04-15
PT837848E (pt)	2002-12-31
TR199701710T1 (xx)	1998-05-21
KR100460581B1 (ko)	2005-04-14
FR2736053B1 (fr)	1997-09-19
AU6461996A (en)	1997-01-30
EP0837848A1 (fr)	1998-04-29
HK1014952A1 (en)	1999-10-08
US5981754A (en)	1999-11-09
CN1189154A (zh)	1998-07-29
HUP9900055A2 (hu)	1999-04-28
HUP9900055A3 (en)	1999-11-29
AU715090B2 (en)	2000-01-13
PL192353B1 (pl)	2006-10-31
ATE223897T1 (de)	2002-09-15
NO310144B1 (no)	2001-05-28
UA62914C2 (en)	2004-01-15
CA2225746C (en)	2004-05-18
EP1216996A2 (fr)	2002-06-26
MX9710472A (es)	1998-03-31
SK178197A3 (en)	1998-07-08
PL187087B1 (pl)	2004-05-31
DK0837848T3 (da)	2003-01-06
SK283707B6 (sk)	2003-12-02
NO976079D0 (no)	1997-12-23

Publication	Publication Date	Title
IS4641A (is)	1997-12-23	4-Arýl-1-fenýlalkýl-1.2.3.6-tetrahýdrópýridín semhafa tauganærandi og taugaverjandi virkni
GR3029408T3 (en)	1999-05-28	Novel piperidine derivatives, useful as neurokinin receptor antagonists
IL115572A0 (en)	1996-01-19	Novel substituted 4-(azanaphthoylamino)-piperidines salts of these and pharmaceutical compositions containing them
NO914218D0 (no)	1991-10-28	Synergistiske ultrafiolettabsorberblandinger inneholdendehydroksyaryltriaziner og tetraalkylpiperidiner
AU3443595A (en)	1996-05-09	Benzylpiperidine derivatives
FR2757056B1 (fr)	2003-03-14	Compositions comprenant un derive de dibenzoylmethane, un derive de 1,3,5-triazine et un compose amide et utilisations
TW341570B (en)	1998-10-01	Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof
DK0958280T3 (da)	2005-08-29	Arylpiperidinopropanol- og arylpiperazinopropanolderivater og farmaceutiske midler der indeholder disse
IL116387A (en)	2000-11-21	5-acyl-1,4-dihydropyridines for control of disorders of CNS with modulating action on potassium channels certain such novel compounds and their preparation
MY120461A (en)	2005-10-31	Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia.
NZ336033A (en)	2000-12-22	4-substituted 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease
MX9801493A (es)	1998-08-30	Amidas del acido fluorbutenoico.